Top Markets
#1 DogBull DogBull +54.86%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +31.07%
#3 OriginTrail OriginTrail +16.39%
#4 MarsCoin MarsCoin +12.31%
#5 DigiByte DigiByte +11.26%
#6 Siren Siren +11.04%
#7 龙虾 (Lobster) 龙虾 (Lobster) +10.68%
#8 Ether.fi Ether.fi +10.50%
#9 Cysic Cysic +10.32%
#10 Ethena Staked ENA Ethena Staked ENA +10.03%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rang in Aktien #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Aktienkurs
$0.3479
Zuletzt synchronisiert: 2024-08-21
Marktkapitalisierung
$94.92M
Veränderung (1 Tag)
0.64%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Asensus Surgical, Inc. (ASXC)

Kategorie

Healthcare
P/S-Verhältnis für Asensus Surgical, Inc. (ASXC)
P/S-Verhältnis zum August 2026 TTM: 11.07
Laut den neuesten Finanzberichten und dem Aktienkurs von Asensus Surgical, Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 11.07. Am Ende des Jahres 2022 lag das P/S-Verhältnis bei 11.58.
P/S-Verlauf für Asensus Surgical, Inc. von 2000 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
2026 (TTM) 11.07 19.26%
2023 9.28 -19.85%
2022 11.58 -62.15%
2021 30.60 117.81%
2020 14.05 359.72%
2019 3.06 -84.27%
2018 19.43 -96.30%
2017 524.82 -57.95%
2016 1.25K 0.00%
2015 0.00 -100.00%
2014 5.54K 1,060.92%
2013 477.12 12,992.32%
2012 3.64 0.00%
2011 0.00 -100.00%
2010 -8.47M 0.00%
2009 0.00 0.00%
2008 0.00 -100.00%
2007 -2.83K 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 46.44 5,218.44%
2002 0.87 -47.76%
2001 1.67 3.81%
2000 1.61 0.00%
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 -62.66%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 -54.52%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -74.84%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 -66.85%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
- -
DE